Webster Bank’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,527
| Closed | -$18.8K | – | 595 |
|
2023
Q3 | $18.8K | Hold |
1,527
| – | – | ﹤0.01% | 406 |
|
2023
Q2 | $18.8K | Hold |
1,527
| – | – | ﹤0.01% | 406 |
|
2023
Q1 | $18.8K | Hold |
1,527
| – | – | ﹤0.01% | 419 |
|
2022
Q4 | $17K | Sell |
1,527
-1,528
| -50% | -$17K | ﹤0.01% | 430 |
|
2022
Q3 | $11K | Hold |
3,055
| – | – | ﹤0.01% | 449 |
|
2022
Q2 | $18K | Hold |
3,055
| – | – | ﹤0.01% | 416 |
|
2022
Q1 | $19K | Hold |
3,055
| – | – | ﹤0.01% | 432 |
|
2021
Q4 | $12K | Hold |
3,055
| – | – | ﹤0.01% | 480 |
|
2021
Q3 | $15K | Hold |
3,055
| – | – | ﹤0.01% | 450 |
|
2021
Q2 | $20K | Hold |
3,055
| – | – | ﹤0.01% | 412 |
|
2021
Q1 | $19K | Hold |
3,055
| – | – | ﹤0.01% | 421 |
|
2020
Q4 | $21K | Hold |
3,055
| – | – | ﹤0.01% | 395 |
|
2020
Q3 | $12K | Hold |
3,055
| – | – | ﹤0.01% | 415 |
|
2020
Q2 | $10K | Hold |
3,055
| – | – | ﹤0.01% | 421 |
|
2020
Q1 | $7K | Hold |
3,055
| – | – | ﹤0.01% | 433 |
|
2019
Q4 | $10K | Hold |
3,055
| – | – | ﹤0.01% | 449 |
|
2019
Q3 | $14K | Sell |
3,055
-828
| -21% | -$3.79K | ﹤0.01% | 415 |
|
2019
Q2 | $18K | Hold |
3,883
| – | – | ﹤0.01% | 403 |
|
2019
Q1 | $21K | Hold |
3,883
| – | – | ﹤0.01% | 389 |
|
2018
Q4 | $12K | Hold |
3,883
| – | – | ﹤0.01% | 408 |
|
2018
Q3 | $16K | Hold |
3,883
| – | – | ﹤0.01% | 421 |
|
2018
Q2 | $15K | Hold |
3,883
| – | – | ﹤0.01% | 423 |
|
2018
Q1 | $25K | Hold |
3,883
| – | – | ﹤0.01% | 415 |
|
2017
Q4 | $31K | Buy |
+3,883
| New | +$31K | ﹤0.01% | 424 |
|
2017
Q3 | – | Sell |
-3,883
| Closed | -$38K | – | 563 |
|
2017
Q2 | $38K | Hold |
3,883
| – | – | 0.01% | 384 |
|
2017
Q1 | $94K | Buy |
+3,883
| New | +$94K | 0.01% | 293 |
|